Insiders · HELP

Michael Halstead

Chief Executive Officer at Cybin Inc. (HELP) since September 2026

Michael Halstead has filed 32 insider reports with the SEC since February 2021, as chief Executive Officer at Cybin Inc. (HELP) and president at Intra-Cellular Therapies, Inc. (ITCI). In the last 12 months Michael Halstead bought $1.35M of stock on the open market. In the latest amended filing, on September 21, 2026, Michael Halstead bought 100,000 shares of Cybin Inc. (HELP) for $1.35M at an average of $13.47.

Filings
32
Companies
2
Bought on market
$1.35M
Sold on market
$24.6M

Companies where Michael Halstead is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Cybin Inc. logo
HELP
Cybin Inc.
Chief Executive Officersince September 2026168,568$1.35M$13.47$7.67-43%Sep 21, 2026
Intra-Cellular Therapies, Inc. logo
ITCI
Intra-Cellular Therapies, Inc.
President0$24.6MApr 2, 2025

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.

Every filing

Also sits on boards with

Officers and directors who share two or more companies with Michael Halstead.

Compare Michael Halstead with

Other insiders at the same companies

Questions about Michael Halstead

What is Michael Halstead's role at Cybin Inc.?
Michael Halstead reports to the SEC as chief Executive Officer at Cybin Inc. (HELP), according to the latest filing on September 21, 2026. Michael Halstead has also filed as president at Intra-Cellular Therapies, Inc. (ITCI).
How many shares does Michael Halstead own?
After the latest filing that states it, Michael Halstead directly owned 168,568 shares of Cybin Inc. (HELP). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Michael Halstead bought or sold stock recently?
The most recent open-market purchase was on September 21, 2026: bought 100,000 shares of Cybin Inc. (HELP) for $1.35M at an average of $13.47. The most recent open-market sale was on November 13, 2024: sold 41,583 shares of Intra-Cellular Therapies, Inc. (ITCI) for $3.69M at an average of $88.79.
How do I get alerts when Michael Halstead files?
Follow Michael Halstead on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Michael Halstead filed 2 times in the last 90 days.

From SEC Forms 3, 4, 5 and 144 filed by Michael Halstead (SEC CIK 0001521548). Totals count each trade once, skipping amendments whose original is on file, from Feb 23, 2021 on. View on SEC EDGAR